Glenview Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-359,381
Closed -$24.9M 58
2022
Q2
$24.9M Hold
359,381
0.62% 33
2022
Q1
$27.6M Sell
359,381
-225,940
-39% -$16.2M 0.56% 37
2021
Q4
$44.8M Sell
585,321
-114,684
-16% -$8.43M 0.96% 33
2021
Q3
$51.7M Sell
700,005
-88,783
-11% -$6.66M 0.94% 35
2021
Q2
$52.6M Buy
788,788
+361,343
+85% +$24.2M 0.87% 37
2021
Q1
$31.8M Sell
427,445
-376,997
-47% -$28.6M 0.54% 42
2020
Q4
$58.6M Sell
804,442
-645,729
-45% -$45.6M 1.34% 23
2020
Q3
$96.4M Sell
1,450,171
-485,564
-25% -$30.7M 3.03% 9
2020
Q2
$110M Sell
1,935,735
-1,974,845
-51% -$96.9M 3.04% 12
2020
Q1
$137M Sell
3,910,580
-6,156,261
-61% -$293M 3.73% 10
2019
Q4
$526M Buy
10,066,841
+1,856,654
+23% +$92.4M 4.6% 7
2019
Q3
$415M Sell
8,210,187
-1,565,060
-16% -$77M 4.36% 7
2019
Q2
$469M Sell
9,775,247
-983,303
-9% -$45.5M 4.25% 7
2019
Q1
$521M Buy
10,758,550
+844,507
+9% +$38.1M 4.65% 8
2018
Q4
$407M Buy
9,914,043
+1,578,935
+19% +$64.8M 3.95% 12
2018
Q3
$342M Buy
8,335,108
+7,105,488
+578% +$287M 2.17% 20
2018
Q2
$48.9M Buy
+1,229,620
New +$47.3M 0.33% 47

Other funds holding HOLX

Glenview Capital Management's HOLX Position: Q3 2022 in Review

Glenview Capital Management sold out of Hologic (HOLX) in Q3 2022, closing a stake of 359,381 shares — an estimated $24.9M sold.

Glenview Capital Management first reported a position in HOLX in Q2 2018 and held it in 17 quarters. The position peaked at $526M in Q4 2019. 654 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

  • Glenview Capital Management reported no remaining Hologic position as of Q3 2022 after selling out during the quarter.
  • Glenview Capital Management sold 359,381 Hologic shares in Q3 2022, an estimated $24.9M.
  • Glenview Capital Management first reported a position in Hologic in Q2 2018 and held it in 17 quarters.
  • Glenview Capital Management's Hologic position peaked at $526M in Q4 2019.
  • 654 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Glenview Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.